secwatch / observer
8-K filed November 3, 2023, 7:59 PM ET ticker HUM CIK 0000049071
debt confidence high sentiment neutral materiality 0.55

Humana prices $1.35B senior notes offering (5.750% due 2028, 5.950% due 2034)

HUMANA INC

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

HUMANA INC entered into Underwriting Agreement with Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Truist Securities, Inc., as representatives of the several underwriters valued at $500 million aggregate principal amount of its 5.750% Senior Notes due 2028 and $850 million aggrega (effective 2023-11-02).

Action
entry
Agreement
underwriting
Counterparty
Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Truist Securities, Inc., as representatives of the several underwriters
Value
$500 million aggregate principal amount of its 5.750% Senior Notes due 2028 and $850 million aggrega
Effective
2023-11-02
Exact text from the filing
On November 2, 2023, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Truist Securities, Inc. , as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $500 million aggregate principal amount of its 5.750% Senior Notes due 2028 (the “2028 Senior Notes”) and $850 million aggregate principal amount of its 5.950% Senior Notes due 2034
View on SEC.gov

Browse all material agreements →

HUMANA INC filing history →

Source: SEC EDGAR
accession 0001628280-23-036761
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.